Yanabu M
Fukuoka Shika Daigaku Gakkai Zasshi. 1989;16(3):423-43.
The effects of upper incisor separation, chronic isoproterenol (IPR) treatment and a combination with both treatments on the submandibular and sublingual glands of rats were examined and compared biochemically, immunohistochemically and radioimmunologically during 7 days after treatment. The findings obtained were as follows: 1. Both submandibular and sublingual glands of rats were significantly enlarged by an orthodontic appliance and chronic IPR treatment, and in combination with both treatments they were much more markedly enlarged additively during 7 days of treatment. This enlargement was followed, in general, by a significant increase of both RNA and DNA contents, and the incorporation of BrdU into the glandular cells, especially acinar cells, with some evidence of hyperplasia and hypertrophy. 2. Enlargement of the submandibular glands induced by orthodontic treatment was mediated via superior cervical ganglion, chorda tympani and lingual nerves, whereas of the sublingual glands mainly via chorda tympani and lingual nerves with some evidence of the mutual interactions among these nerves. 3. The secretory functions of the submandibular glands were significantly reduced at early stages after orthodontic treatment in contrast to those of chronic IPR treatment with and without orthodontic treatment. 4. The synthesis of LM protein, mainly localized in the acinar cells, was increased by orthodontic treatment in combination with adrenergic blockers, prazosin, metoprolol and ICI 118551, whereas in chronic IPR treatment it was significantly reduced by metoprolol, but not by prazosin and ICI 118551. LM protein was secreted into saliva at 6 h after IPR treatment.
研究了上切牙分离、慢性异丙肾上腺素(IPR)处理以及二者联合处理对大鼠下颌下腺和舌下腺的影响,并在处理后7天内通过生化、免疫组化和放射免疫方法进行了比较。结果如下:1. 正畸矫治器和慢性IPR处理均可使大鼠下颌下腺和舌下腺显著增大,二者联合处理时,在处理的7天内增大更为明显。这种增大通常伴随着RNA和DNA含量的显著增加,以及BrdU掺入腺细胞,尤其是腺泡细胞,有一些增生和肥大的证据。2. 正畸治疗引起的下颌下腺增大通过颈上神经节、鼓索神经和舌神经介导,而舌下腺增大主要通过鼓索神经和舌神经介导,这些神经之间有一些相互作用的证据。3. 与慢性IPR处理(无论是否联合正畸治疗)相比,正畸治疗后早期下颌下腺的分泌功能显著降低。4. 正畸治疗联合肾上腺素能阻滞剂哌唑嗪、美托洛尔和ICI 118551可增加主要定位于腺泡细胞的LM蛋白的合成,而在慢性IPR处理中,美托洛尔可使其显著降低,但哌唑嗪和ICI 118551则无此作用。IPR处理后6小时,LM蛋白分泌到唾液中。